REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
RNS Number : 8941JBank of America Merrill Lynch16 April 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
15/04/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
215,740
0.015%
2,489,826
0.169 %
(2)
Derivatives (other than options):
2,055,968
0.139%
146,148
0.01%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,279,108
0.154%
2,643,474
0.179%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
4,232
81.949 USD
Purchase
1
79.67 USD
Purchase
1
79.68 USD
Purchase
2
79.69 USD
Purchase
2
79.75 USD
Purchase
3
79.76 USD
Purchase
3
79.77 USD
Purchase
1
79.78 USD
Purchase
3
79.79 USD
Purchase
1
79.8 USD
Purchase
2
79.81 USD
Purchase
6
79.84 USD
Purchase
2
79.86 USD
Purchase
2
79.88 USD
Purchase
4
79.9 USD
Purchase
5
79.92 USD
Purchase
2
79.93 USD
Purchase
1
79.95 USD
Purchase
2
79.96 USD
Purchase
4
79.97 USD
Purchase
2
80.03 USD
Purchase
4
80.05 USD
Purchase
4
80.09 USD
Purchase
8
80.1 USD
Purchase
8
80.14 USD
Purchase
100
80.15 USD
Purchase
1
80.16 USD
Purchase
88
80.17 USD
Purchase
78
80.18 USD
Purchase
89
80.19 USD
Purchase
2
80.2 USD
Purchase
87
80.21 USD
Purchase
280
80.23 USD
Purchase
2
80.24 USD
Purchase
198
80.27 USD
Purchase
204
80.28 USD
Purchase
100
80.285 USD
Purchase
87
80.29 USD
Purchase
213
80.3 USD
Purchase
200
80.31 USD
Purchase
260
80.32 USD
Purchase
163
80.33 USD
Purchase
92
80.34 USD
Purchase
4
80.35 USD
Purchase
4
80.38 USD
Purchase
134
80.39 USD
Purchase
87
80.4 USD
Purchase
91
80.41 USD
Purchase
100
80.42 USD
Purchase
4
80.43 USD
Purchase
4
80.47 USD
Purchase
1
80.48 USD
Purchase
1
80.49 USD
Purchase
6
80.5 USD
Purchase
173
80.53 USD
Purchase
204
80.55 USD
Purchase
127
80.56 USD
Purchase
173
80.57 USD
Purchase
50
80.6 USD
Purchase
136
80.61 USD
Purchase
300
80.614 USD
Purchase
146
80.62 USD
Purchase
286
80.63 USD
Purchase
101
80.67 USD
Purchase
2
80.68 USD
Purchase
260
80.69 USD
Purchase
100
80.73 USD
Purchase
200
80.77 USD
Purchase
237
80.79 USD
Purchase
86
80.81 USD
Purchase
275
80.82 USD
Purchase
86
80.83 USD
Purchase
100
80.84 USD
Purchase
173
80.85 USD
Purchase
48
80.87 USD
Purchase
201
81.06 USD
Purchase
228
81.8 USD
Purchase
10
81.81 USD
Purchase
1,897
81.82 USD
Purchase
13
81.87 USD
Purchase
10
81.96 USD
Purchase
11
81.97 USD
Purchase
10
82 USD
Purchase
14
82.54 USD
Purchase
100
82.565 USD
Purchase
200
82.58 USD
Purchase
100
82.595 USD
Purchase
12
82.6 USD
Purchase
197
82.61 USD
Purchase
200
82.835 USD
Purchase
100
82.85 USD
Purchase
100
82.88 USD
Purchase
77
82.91 USD
Purchase
200
82.96 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
217
81.82 USD
Sale
1,300
82.745 USD
Sale
1
79.69 USD
Sale
1
79.72 USD
Sale
2
79.8 USD
Sale
2
79.81 USD
Sale
1
79.87 USD
Sale
1
79.89 USD
Sale
1
79.9 USD
Sale
1
79.92 USD
Sale
2
79.96 USD
Sale
1
79.97 USD
Sale
1
79.99 USD
Sale
1
80 USD
Sale
1
80.03 USD
Sale
1
80.07 USD
Sale
1
80.12 USD
Sale
1
80.15 USD
Sale
2
80.17 USD
Sale
1
80.18 USD
Sale
2
80.22 USD
Sale
1
80.23 USD
Sale
1
80.3 USD
Sale
1
80.31 USD
Sale
1
80.35 USD
Sale
1
80.39 USD
Sale
3
80.4 USD
Sale
101
80.41 USD
Sale
100
80.411 USD
Sale
87
80.42 USD
Sale
1
80.43 USD
Sale
19
80.46 USD
Sale
1
80.51 USD
Sale
100
80.55 USD
Sale
1
80.56 USD
Sale
1
80.62 USD
Sale
1
81.45 USD
Sale
1
81.47 USD
Sale
1
81.53 USD
Sale
1
81.59 USD
Sale
189
81.74 USD
Sale
606
81.75 USD
Sale
353
81.77 USD
Sale
100
81.78 USD
Sale
1
81.79 USD
Sale
1,378
81.807 USD
Sale
29,888
81.82 USD
Sale
3
81.84 USD
Sale
164
81.85 USD
Sale
387
81.86 USD
Sale
100
81.89 USD
Sale
19
81.93 USD
Sale
174
81.94 USD
Sale
86
81.97 USD
Sale
124
81.98 USD
Sale
86
81.99 USD
Sale
180
82 USD
Sale
100
82.055 USD
Sale
72
82.06 USD
Sale
433
82.07 USD
Sale
100
82.085 USD
Sale
200
82.09 USD
Sale
100
82.095 USD
Sale
373
82.1 USD
Sale
469
82.11 USD
Sale
223
82.12 USD
Sale
100
82.14 USD
Sale
2
82.16 USD
Sale
100
82.18 USD
Sale
1
82.23 USD
Sale
200
82.26 USD
Sale
173
82.29 USD
Sale
87
82.3 USD
Sale
100
82.31 USD
Sale
100
82.32 USD
Sale
50
82.35 USD
Sale
1
82.36 USD
Sale
256
82.4 USD
Sale
278
82.42 USD
Sale
286
82.43 USD
Sale
1
82.46 USD
Sale
172
82.47 USD
Sale
180
82.48 USD
Sale
750
82.49 USD
Sale
942
82.5 USD
Sale
686
82.51 USD
Sale
300
82.52 USD
Sale
86
82.57 USD
Sale
283
82.58 USD
Sale
97
82.6 USD
Sale
358
82.61 USD
Sale
600
82.62 USD
Sale
199
82.63 USD
Sale
174
82.64 USD
Sale
274
82.65 USD
Sale
634
82.66 USD
Sale
287
82.67 USD
Sale
374
82.68 USD
Sale
371
82.69 USD
Sale
373
82.7 USD
Sale
400
82.71 USD
Sale
399
82.72 USD
Sale
50
82.73 USD
Sale
150
82.74 USD
Sale
160
82.75 USD
Sale
571
82.76 USD
Sale
101
82.77 USD
Sale
100
82.78 USD
Sale
590
82.79 USD
Sale
86
82.795 USD
Sale
200
82.8 USD
Sale
400
82.81 USD
Sale
199
82.815 USD
Sale
13
82.82 USD
Sale
187
82.825 USD
Sale
101
82.83 USD
Sale
100
82.98 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Increasing a Long Position
2,354
81.82 USD
Swaps
Reducing a Long Position
139
80.146 USD
Swaps
Reducing a Short Position
1,353
81.809 USD
Swaps
Reducing a Short Position
25
81.31 USD
Swaps
Reducing a Long Position
300
80.614 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Borrow
Borrow of 759,000 shares
N/A
Borrow
Borrow of 1,136,900 shares
N/A
Borrow
Borrow of 1,731,500 shares
N/A
Borrow
Borrow of 134,200 shares
N/A
Borrow
Borrow of 52,600 shares
N/A
Borrow
Borrow of 93,000 shares
N/A
Borrow
Borrow of 4,300 shares
N/A
Borrow
Borrow of 589,800 shares
N/A
Loan
Loan of 4,300 shares
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
16/04/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEKQLBFBZLEBBE
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement